Dr. Jeremy Levin on Misinformation's Impact on Evidence-Based Science

In an interview with Pharmaceutical Executive, Dr. Jeremy Levin, author of 'Biotech in the Balance,' discusses the detrimental impact of misinformation on evidence-based medicine and the biotechnology industry. Amidst turbulent leadership changes at US health agencies, including the reported removal of Marty Makary from the FDA, Levin emphasizes the need to address capital market relationships and resist the politicization of medical research. He highlights the media's failure to curate information, noting that outlets often repeat unverified claims rather than verifying them. Levin cites the retracted Lancet article linking MMR vaccines to autism as a prime example of how scientific errors, when not aggressively corrected by publications, lead to long-term public distrust and vaccine hesitancy. This misinformation has contributed to the resurgence of measles in the United States and poses significant risks for future pandemic responses. Levin argues that scientific journals and media must take greater responsibility for clarifying past errors to combat the spread of false narratives that undermine public health initiatives and strategic industry stability.